2001-May Archives by Author

• Messages sorted by: [ thread ] [ subject ] [ date ]
• More info on this list...

Starting: Tue May 1 06:52:04 2001
Ending: Thu May 31 17:50:01 2001
Messages: 113

• [Pharm-policy] Sleeping sickness drugs back in production (MSF)   ACCESS-Com
• [Pharm-policy] Re: Pharm-policy digest, Vol 1 #362 - 5 msgs   Alacran7@aol.com
• [Pharm-policy] EU rules against GSK on Parallel Imports   Alacran7@aol.com
• [Pharm-policy] Note to Piot re Monday's bad quote   Alacran7@aol.com
• [Pharm-policy] Latest world pharma market summary - 13 key markets   Alacran7@aol.com
• [Pharm-policy] Fwd: NYC June 23: Stop Global AIDS Now March & Rally   Alacran7@aol.com
• [Pharm-policy] (no subject)   Kathryn Biberstein
• [mtandao] [Pharm-policy] [Ip-health] Abuja Declaration on HI   Chintowa, Patrick
• [Pharm-policy] please unsubscribe me   Adrian Constant
• [Pharm-policy] New York panel on the international AIDS crisis   David_VEAZEY%INTERNET@amsterdam.msf.org
• [Pharm-policy] Wash Post: US Panel Suggests Rules For Foreign Drug Tests   Paul Davis
• [Pharm-policy] Washpost: House IR Panel Reverses Bush Family Planning Garbage   Paul Davis
• [Pharm-policy] Reuters: Brazil slams UN, US for shortsighted AIDS policies   Paul Davis
• [Pharm-policy] FW: Wall Street Journal: Bush Administration Weighs Donation Of $200 Million to U.N. AIDS Fund   Paul Davis
• [Pharm-policy] [breaking-the-silence] WSJ, AP: Mining Firm Anglo American Offers AIDS Drugs to Workers   Paul Davis
• [Pharm-policy] Re: [Ip-health] TACD resolution on medicines   Paul Davis
• [Pharm-policy] [breaking-the-silence] WSJ, AP: Mining Firm Anglo American Offers AIDS Drugs to Workers   Paul Davis
• [Pharm-policy] [breaking-the-silence] WSJ, AP: Mining Firm Anglo American Offers AIDS Drugs to Workers   Paul Davis
• [Pharm-policy] URGENT: Call Powell on Undermining UN Fund for AIDS   Paul Davis
• [Pharm-policy] Global Fund Reccomendations and Principles   Paul Davis
• [Pharm-policy] Request: info on meetings on global fund   Paul Davis
• [Pharm-policy] FW: reuters: Powell attacked in Kenya over U.S. AIDS policy   Paul Davis
• [Pharm-policy] trials in developing countries   Liza Dawson
• [Pharm-policy] NYTimes: US Drug spending up 18.8%   Edawrd DeGrenier
• [Pharm-policy] RE: [Ip-health] Schumer McCain Bill: Make Generics Avail in USA   Dehoney, Eleanor
• [Pharm-policy] Oxfam paper re Brazil   Richard Elliott
• [Pharm-policy] RE: [Ip-health] Schumer McCain Bill: Make Generics Avail in USA   Gonsalves, Gregg
• [Pharm-policy] Job opportunity: Campaigns Director for HAI Europe Office   Hilbrand Haak
• [Pharm-policy] Amy and Goliath - Salon on Amy's role in Yale d4T patent campaign   James Love
• [Pharm-policy] [Ip-health] African Leaders Back Less Costly AIDS Drugs,More Spending   James Love
• [Pharm-policy] TACD meeting   James Love
• [Pharm-policy] TACD   James Love
• [Pharm-policy] Brazil responds to USTR criticism   James Love
• [Pharm-policy] TACD resolution on medicines   James Love
• [Pharm-policy] CIPLA/Anglo discussions   James Love
• [Pharm-policy] Re: [Ip-health] TACD resolution on medicines   James Love
• [Pharm-policy] TAC Statement on BMS   James Love
• [Pharm-policy] Sunday Times on Anglo CIPLA deal   James Love
• [Pharm-policy] Ranbaxy in Inda, CIPLA's SA compulsory licensing request   James Love
• [Pharm-policy] Final TACD resolution on medicines   James Love
• [Pharm-policy] Text of HR 1708, US compulsory licensing legislation   James Love
• [Pharm-policy] CIPLA's Triomune 3 in one pill   James Love
• [Pharm-policy] Susan Finston asks about CIPLA's Triomune 3 in one pill]   James Love
• [Pharm-policy] RJ comment to: Susan Finston asks about CIPLA's Triomune 3 in on e pill   James Love
• [Pharm-policy] Gray Panthers Press release   James Love
• [Pharm-policy] Database on Scientists & Conflicts of Interest   James Love
• [Pharm-policy] my Geneva number   James Love
• [Pharm-policy] NGOs MUST apply for Qatar accreditation by July 2nd!]   James Love
• [Pharm-policy] the Economists on WHA fight over resolutions   James Love
• [Pharm-policy] Science journals - revolt by authors   James Love
• [Pharm-policy] TAP PHARMACEUTICALS: To Pay Record Fine Over Drug Pricing]   James Love
• [Pharm-policy] Sam in Salon   James Love
• [Pharm-policy] OAPI memo on MSF and UNAIDS critique of Bangui agreement   James Love
• [Pharm-policy] CIPLA complusory licensing request   James Love
• [Pharm-policy] Medical Innovation Conference June 14/15   James Love
• [Pharm-policy] India Asks for WTO Talks With Argentina on Drug Import Rules   James Love
• [Pharm-policy] EU Health TRIPS Issues group   James Love
• [Pharm-policy] WTO meeting on essential medicines -Where are the NGOs?   James Love
• [Pharm-policy] EU PUSHES PHARMACEUTICAL INDUSTRY TO DELIVER MEDICINES TO POOREST (Ref:4GZLKD)]   James Love
• [Pharm-policy] Re: [Ip-health] Brazil responds to USTR criticism   MFJorge@aol.com
• [Pharm-policy] NYT: Microsoft Is Set to Be Top Foe of Free Code   Robert Naiman
• [Pharm-policy] Waters introduces bill to punish pharmaceutical companies for blocking access to treatment   Robert Naiman
• [Pharm-policy] Russia Balks at World Bank TB Aid   Robert Naiman
• [Pharm-policy] Final Declarations from Quebec meeting   Mike Palmedo
• [Pharm-policy] Business Report: Cipla to apply for a compulsory licence to manufacture HIV/Aids drugs locally   Mike Palmedo
• [Pharm-policy] [Fwd: Brazil responds to USTR criticism]   Mike Palmedo
• [Pharm-policy] Reuters on market exclusivity extentions for pediatric tests   Mike Palmedo
• [Pharm-policy] NYTimes: US Drug spending up 18.8%   Mike Palmedo
• [Pharm-policy] NYT: Suits Accuse Drug Makers of Keeping generics Off-Market   Mike Palmedo
• [Pharm-policy] Bad junk mail post   Mike Palmedo
• [Pharm-policy] Cosatu Statement on Anglo American Treatment Programme   Mike Palmedo
• [Pharm-policy] Activists Protest U.S. Paltry Global AIDS Contribution   Mike Palmedo
• [Pharm-policy] Reuters on Debt cancellation for AIDS Fund   Mike Palmedo
• [Pharm-policy] HIV/AIDS Proposal the WHA will not circulate   Mike Palmedo
• [Pharm-policy] Revised Drug Strategy Proposede Resolution - WHA won't circulate   Mike Palmedo
• [Pharm-policy] HIV and RDS proposed resolutions   Mike Palmedo
• [Pharm-policy] Reuters: WHO to adapt AIDS Resolution   Mike Palmedo
• [Pharm-policy] (no subject)   Mike Palmedo
• [Pharm-policy] [Fwd: global fund doc]   Mike Palmedo
• [Pharm-policy] CNN on Powell's Africa trip   Mike Palmedo
• [Pharm-policy] WTO Fact Sheet on TRIPS and Pharmaceuticals   Mike Palmedo
• [Pharm-policy] Thommy Thompson on access to ARVs (from last week)   Mike Palmedo
• [Pharm-policy] The Hindu on Universal and Free AIDS Care   Mike Palmedo
• [Pharm-policy] Glaxo Press Release   Mike Palmedo
• [Pharm-policy] Washington Post lists new PhRMA lobbyists   Mike Palmedo
• [Pharm-policy] Fw: Press Release : Western Journal of Medicine   Prof. Udo Schuklenk
• [Pharm-policy] trials in developing countries   Prof. Udo Schuklenk
• [Pharm-policy] New participant   Diana G Smith
• [Pharm-policy] Schumer McCain Bill: Make Generics Avail in USA   Robert Weissman
• [Pharm-policy] BMS Rumored to Offer Discounts to SA Private Sector   Robert Weissman
• [Pharm-policy] WHO ANNOTATED BIBLIOGRAPHY ON PATENTS AND DRUGS   fresled@who.ch
• [Pharm-policy] Promotional Products   gifts@gnaol.com
• [Pharm-policy] FT on EU/Glaxo parallel import decision   love@cptech.org
• [Pharm-policy] EU efforts to expand parallel trade   love@cptech.org
• [Pharm-policy] AP story on lawsuits over generice entry to US market   love@cptech.org
• [Pharm-policy] Abbott loses curosurf evergreening patent suit   love@cptech.org
• [Pharm-policy] Report from Kenya on battle over access to medicines   love@cptech.org
• [Pharm-policy] US litigation over Cardizem evergreening conspiracy   love@cptech.org
• [Pharm-policy] Canada study on cost of slow generic entry   love@cptech.org
• [Pharm-policy] American Biogenetics' calls for compulsory licensing law in US   love@cptech.org
• [Pharm-policy] UK on genetic test patents   love@cptech.org
• [Pharm-policy] BountyQuest busts 1st biotech patent (Incyte genomic patent)   love@cptech.org
• [Pharm-policy] Submarine-stealth genetic patents deadly for research   love@cptech.org
• [Pharm-policy] patent on crucial technology used by dozens of companies for gene therapy experiments   love@cptech.org
• [Pharm-policy] Malaysian compulsory licensing law   love@cptech.org
• [Pharm-policy] Patent on Business method for managing genomic technologies   love@cptech.org
• [Pharm-policy] Richard Holbrooke joins Human Genome Sciences board   love@cptech.org
• [Pharm-policy] Biotech Patent Guru Discusses Proteomics Patent Wars   love@cptech.org
• [Pharm-policy] NORD endorses compulsory license for gene patents used in research   love@cptech.org
• [Pharm-policy] Jon Merz on Gene Patents and Other Genomic inventions   love@cptech.org
• [Pharm-policy] Exxon Mobil seeks compulsory license of Unocal anti-smog patent   love@cptech.org
• [Pharm-policy] Kreeger and Park on Remune conflict of interest story   love@cptech.org
• [Pharm-policy] (no subject)   qamar zaman

Last message date: Thu May 31 17:50:01 2001
Archived on: Thu May 31 16:50:01 2001

• Messages sorted by: [ thread ] [ subject ] [ date ]
• More info on this list...